Search

Your search keyword '"Prescott G"' showing total 2,067 results

Search Constraints

Start Over You searched for: Author "Prescott G" Remove constraint Author: "Prescott G"
2,067 results on '"Prescott G"'

Search Results

1. Microbial dynamics and pulmonary immune responses in COVID-19 secondary bacterial pneumonia

2. Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19

3. A common polymorphism in the Intelectin-1 gene influences mucus plugging in severe asthma

4. A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD

5. Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS

6. An essential role for miR-15/16 in Treg suppression and restriction of proliferation

7. A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling

8. Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19

9. Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease

10. Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS

11. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study

12. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium

13. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD

14. Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort

15. Latent traits of lung tissue patterns in former smokers derived by dual channel deep learning in computed tomography images

16. Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort

17. 15LO1 dictates glutathione redox changes in asthmatic airway epithelium to worsen type 2 inflammation

18. High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis

19. Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS)

20. Microbial dynamics and pulmonary immune responses in COVID-19 secondary bacterial pneumonia

21. Peroxidase-mediated mucin cross-linking drives pathologic mucus gel formation in IL-13-stimulated airway epithelial cells

22. Immediate myeloid depot for SARS-CoV-2 in the human lung

23. Epithelial miR-141 regulates IL-13–induced airway mucus production

24. The influence of social support on COPD outcomes mediated by depression.

25. T-bet Expression in Peripheral Th17.0 Cells Is Associated With Pulmonary Function Changes in Sarcoidosis

26. Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort

27. Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

28. Genome-wide association study of lung function and clinical implication in heavy smokers

29. Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD

30. ROP: dumpster diving in RNA-sequencing to find the source of 1 trillion reads across diverse adult human tissues

31. Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori

33. A common polymorphism in the Intelectin-1 gene influences mucus plugging in severe asthma

34. Pneumoproteins are associated with pulmonary function in HIV-infected persons.

35. Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthma

36. Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study

37. Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS.

38. An essential role for miR-15/16 in Treg suppression and restriction of proliferation

39. A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling

40. Variability in objective and subjective measures affects baseline values in studies of patients with COPD.

41. Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.

42. COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry.

43. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD

44. The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma.

45. Accumulation of BDCA1⁺ dendritic cells in interstitial fibrotic lung diseases and Th2-high asthma.

46. Author Correction: New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries

47. COVID-19–associated Lung Microvascular Endotheliopathy: A “From the Bench” Perspective

48. Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function

49. Risk of COPD exacerbation is increased by poor sleep quality and modified by social adversity.

Catalog

Books, media, physical & digital resources